John G. Watkin

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder

Stephen K. Brannan, Craig Mallinckrodt, Eileen B. Brown et al. · Journal of Psychiatric Research · 2004 · 181 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Sexual Functioning Assessed in 4 Double-Blind Placebo- and Paroxetine-Controlled Trials of Duloxetine for Major Depressive Disorder

Pedro L. Delgado, Stephen K. Brannan, Craig Mallinckrodt et al. · The Journal of Clinical Psychiatry · 2005 · 135 citations

Medicine, Pharmacotherapy, Psychiatry +17

Choice of the primary analysis in longitudinal clinical trials

Craig Mallinckrodt, John G. Watkin, Geert Molenberghs et al. · Pharmaceutical Statistics · 2004 · 122 citations

Public Health, Biostatistics, Clinical Epidemiology +16

The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA

Craig Mallinckrodt, Christopher Kaiser, John G. Watkin et al. · Clinical Trials · 2004 · 96 citations

Public Health, Biostatistics, Epidemiologic Methods +16

Duloxetine for the Treatment of Major Depressive Disorder in Older Patients

J. Craig Nelson, Madelaine M. Wohlreich, Craig Mallinckrodt et al. · American Journal of Geriatric Psychiatry · 2005 · 67 citations

Medicine, Pharmacotherapy, Psychiatry +14